Trademark Overview
On Tuesday, February 18, 2025, a trademark application was filed for AUTONOMY BIO with the United States Patent and Trademark Office. The USPTO has given the AUTONOMY BIO trademark a serial number of 99046434. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 18, 2025. This trademark is owned by Autonomy Bio, Inc.. The AUTONOMY BIO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for anti-aging, including drugs formulated to delay or reverse age-related physiological decline; Prescription and over-the-counter medications for preventing or delaying human aging; Pharmaceutical compounds designed for reducing or reversing declines associated with aging; Therapeutic agents for improving skin and systemic health through pharmaceutical intervention; Medical preparations for increasing healthspan and lifespan.; Gene therapy products, namely, genetically engineered tissues for anti-aging purposes; Stem cells for medical purposes; Biologic tissue products, namely, genetically engineered tissues and stem cells for use in regenerative medicine; Nutraceuticals for use as a dietary supplement for delaying or reversing age-related decline; Pharmaceutical products for the personalized treatment for delaying or reversing age-related decline; Wearable drug delivery devices sold filled with pharmaceutical preparations for delaying or reversing age-rel...
Stem cell therapy services; Regenerative medicine services
Pharmaceutical research and development services focusing on anti-aging and longevity therapeutics; Drug discovery platform for identifying drug synergies and optimizing clinical trial protocols; Scientific research and consulting in the field of gerontology and human anti-aging.; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Stem cell research services; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for use in machine learning for predicting and optimizing human lifespan; Performing scientific research or providing scientific research services to identify novel biomarkers to aid in new drug development and clinical trial processes related to delaying or reversing age-related decline; Consulting services for others in the field of design, planning, and implementation project management of clinical trials for anti-aging drugs
